4644. Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
作者: Emi Takashita.;Noriko Kinoshita.;Seiya Yamayoshi.;Yuko Sakai-Tagawa.;Seiichiro Fujisaki.;Mutsumi Ito.;Kiyoko Iwatsuki-Horimoto.;Shiho Chiba.;Peter Halfmann.;Hiroyuki Nagai.;Makoto Saito.;Eisuke Adachi.;David Sullivan.;Andrew Pekosz.;Shinji Watanabe.;Kenji Maeda.;Masaki Imai.;Hiroshi Yotsuyanagi.;Hiroaki Mitsuya.;Norio Ohmagari.;Makoto Takeda.;Hideki Hasegawa.;Yoshihiro Kawaoka.
来源: N Engl J Med. 2022年386卷10期995-998页 4645. Lung Transplantation for Covid-19-Related Respiratory Failure in the United States.
作者: Amy Roach.;Joanna Chikwe.;Pedro Catarino.;Reinaldo Rampolla.;Paul W Noble.;Dominick Megna.;Qiudong Chen.;Dominic Emerson.;Natalia Egorova.;Shaf Keshavjee.;James K Kirklin.
来源: N Engl J Med. 2022年386卷12期1187-1188页 4646. SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
作者: Rolando Pajon.;Nicole A Doria-Rose.;Xiaoying Shen.;Stephen D Schmidt.;Sijy O'Dell.;Charlene McDanal.;Wenhong Feng.;Jin Tong.;Amanda Eaton.;Maha Maglinao.;Haili Tang.;Kelly E Manning.;Venkata-Viswanadh Edara.;Lilin Lai.;Madison Ellis.;Kathryn M Moore.;Katharine Floyd.;Stephanie L Foster.;Christine M Posavad.;Robert L Atmar.;Kirsten E Lyke.;Tongqing Zhou.;Lingshu Wang.;Yi Zhang.;Martin R Gaudinski.;Walker P Black.;Ingelise Gordon.;Mercy Guech.;Julie E Ledgerwood.;John N Misasi.;Alicia Widge.;Nancy J Sullivan.;Paul C Roberts.;John H Beigel.;Bette Korber.;Lindsey R Baden.;Hana El Sahly.;Spyros Chalkias.;Honghong Zhou.;Jing Feng.;Bethany Girard.;Rituparna Das.;Anne Aunins.;Darin K Edwards.;Mehul S Suthar.;John R Mascola.;David C Montefiori.
来源: N Engl J Med. 2022年386卷11期1088-1091页 4648. Effects of a Prolonged Booster Interval on Neutralization of Omicron Variant.
作者: Xin Zhao.;Dedong Li.;Wenjing Ruan.;Zhihai Chen.;Rong Zhang.;Anqi Zheng.;Shitong Qiao.;Xinlei Zheng.;Yingze Zhao.;Lianpan Dai.;Pengcheng Han.;George F Gao.
来源: N Engl J Med. 2022年386卷9期894-896页 4649. Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.
作者: Dror Mevorach.;Emilia Anis.;Noa Cedar.;Tal Hasin.;Michal Bromberg.;Lital Goldberg.;Elchanan Parnasa.;Rita Dichtiar.;Yael Hershkovitz.;Nachman Ash.;Manfred S Green.;Lital Keinan-Boker.;Sharon Alroy-Preis.
来源: N Engl J Med. 2022年386卷10期998-999页 4651. Homologous and Heterologous Covid-19 Booster Vaccinations.
作者: Robert L Atmar.;Kirsten E Lyke.;Meagan E Deming.;Lisa A Jackson.;Angela R Branche.;Hana M El Sahly.;Christina A Rostad.;Judith M Martin.;Christine Johnston.;Richard E Rupp.;Mark J Mulligan.;Rebecca C Brady.;Robert W Frenck.;Martín Bäcker.;Angelica C Kottkamp.;Tara M Babu.;Kumaravel Rajakumar.;Srilatha Edupuganti.;David Dobrzynski.;Rhea N Coler.;Christine M Posavad.;Janet I Archer.;Sonja Crandon.;Seema U Nayak.;Daniel Szydlo.;Jillian A Zemanek.;Clara P Dominguez Islas.;Elizabeth R Brown.;Mehul S Suthar.;M Juliana McElrath.;Adrian B McDermott.;Sarah E O'Connell.;David C Montefiori.;Amanda Eaton.;Kathleen M Neuzil.;David S Stephens.;Paul C Roberts.;John H Beigel.; .
来源: N Engl J Med. 2022年386卷11期1046-1057页
Although the three vaccines against coronavirus disease 2019 (Covid-19) that have received emergency use authorization in the United States are highly effective, breakthrough infections are occurring. Data are needed on the serial use of homologous boosters (same as the primary vaccine) and heterologous boosters (different from the primary vaccine) in fully vaccinated recipients.
|